Esco Lifesciences (Singapore, Esco Micro Pte. Ltd.) manufactures primary containment and bioprocessing equipment across a broad pharma portfolio: Class II BSCs (NSF/ANSI 49-certified), hard-wall and flexible film isolators, HEPA-filtered downflow booths and pass boxes, cytotoxic cabinets, ventilated balance enclosures, CO₂ incubators with high-heat decontamination cycles, tide-motion and rocking bioreactors (CelCradle® platform, including BSL-3/4-rated configurations), and ceiling-mount laminar airflow units.
Relevant to USP 797/800 compounding suites, cell therapy manufacturing, gene therapy upstream, and GMP fill-finish support environments. Esco Aster (subsidiary CRDMO) extends the offering into upstream/downstream process development and contract fill-finish.